Jury Deadlocks In Wyeth Hormone Replacement Trial

Law360, New York (September 28, 2006, 12:00 AM EDT) -- Jurors in the first state court trial over claims that Wyeth’s hormone replacement therapy drugs increase the risk of heart disease, stroke and cancer remained deadlocked on Thursday, with the judge ordering them back to court on Friday to attempt to reach a verdict.

The jury, comprising five men and three women, has been in deliberations for nearly 16 hours, but "right now, there's an impasse," according to Judge Norman Ackerman of the Philadelphia Court of Common Pleas, Reuters reported. "It's important for all parties that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.